SLC1A2 and amyotrophic lateral sclerosis: Reducing GLT‐1 expression aggravates disease severity in rodent models of amyotrophic lateral sclerosis (Pardo et al. 2006) and Alzheimer's disease (Mookherjee et al. 2011).